STOCK TITAN

LeMaitre Will Announce First Quarter 2024 Earnings Results May 2, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
LeMaitre Vascular, Inc. (LMAT) will announce its first quarter 2024 financial results on May 2, 2024, after the market close. A conference call is scheduled for 5:00 PM ET the same day to discuss business highlights and outlook.
LeMaitre Vascular, Inc. (LMAT) annuncerà i risultati finanziari del primo trimestre del 2024 il 2 maggio 2024, dopo la chiusura del mercato. È prevista una conferenza telefonica alle ore 17:00 ET dello stesso giorno per discutere i punti salienti dell'attività e le prospettive future.
LeMaitre Vascular, Inc. (LMAT) anunciará los resultados financieros del primer trimestre de 2024 el 2 de mayo de 2024, después del cierre del mercado. Se ha programado una llamada de conferencia para las 5:00 PM ET del mismo día para discutir los aspectos destacados del negocio y las perspectivas.
LeMaitre Vascular, Inc. (LMAT)는 2024년 5월 2일 시장 마감 후 2024년도 1분기 재무 결과를 발표할 예정입니다. 같은 날 오후 5시 ET에 사업 하이라이트와 전망에 대해 논의하기 위한 전화 회의가 예정되어 있습니다.
LeMaitre Vascular, Inc. (LMAT) annoncera ses résultats financiers pour le premier trimestre 2024 le 2 mai 2024, après la fermeture du marché. Une conférence téléphonique est programmée à 17h00 ET le même jour pour discuter des points forts de l'entreprise et des perspectives.
LeMaitre Vascular, Inc. (LMAT) wird seine Finanzergebnisse für das erste Quartal 2024 am 2. Mai 2024 nach Börsenschluss bekannt geben. Eine Telefonkonferenz ist für 17:00 Uhr ET am selben Tag angesetzt, um Geschäftshöhepunkte und Ausblicke zu diskutieren.
Positive
  • None.
Negative
  • None.

BURLINGTON, Mass., April 19, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2024 financial results on Thursday, May 2, 2024, after the market close. The company has scheduled a conference call for 5:00 PM ET the same day to discuss the results, business highlights, and company outlook.

Access to the live call is available by registering online here. All registrants will receive dial-in information and a PIN allowing them to access the live call. The audio webcast can also be accessed live or via replay through a webcast at www.lemaitre.com/investor.

About LeMaitre

LeMaitre is a provider of devices, implants, and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.

LeMaitre and the LeMaitre logo are registered trademarks of LeMaitre Vascular, Inc.


FAQ

When will LeMaitre Vascular, Inc. (LMAT) announce its first quarter 2024 financial results?

LeMaitre Vascular, Inc. (LMAT) will announce its first quarter 2024 financial results on May 2, 2024, after the market close.

What time is the conference call scheduled for to discuss the first quarter 2024 financial results of LeMaitre Vascular, Inc. (LMAT)?

The conference call to discuss the first quarter 2024 financial results of LeMaitre Vascular, Inc. (LMAT) is scheduled for 5:00 PM ET on May 2, 2024.

How can I access the live call to discuss the first quarter 2024 financial results of LeMaitre Vascular, Inc. (LMAT)?

You can access the live call to discuss the first quarter 2024 financial results of LeMaitre Vascular, Inc. (LMAT) by registering online for the conference call and receiving dial-in information and a PIN.

Where can I find the audio webcast of the first quarter 2024 financial results discussion for LeMaitre Vascular, Inc. (LMAT)?

The audio webcast of the first quarter 2024 financial results discussion for LeMaitre Vascular, Inc. (LMAT) can be accessed live or via replay through a webcast at www.lemaitre.com/investor.

LeMaitre Vascular, Inc.

NASDAQ:LMAT

LMAT Rankings

LMAT Latest News

LMAT Stock Data

1.50B
20.03M
10.21%
91.35%
3.47%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
BURLINGTON

About LMAT

lemaitre vascular is a provider of devices and implants for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. the company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. the company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. the company is listed on nasdaq.